A61Q19/06

Subcutaneous injection formulation for reducing body weight and uses thereof
10716824 · 2020-07-21 · ·

The present invention provides a subcutaneous injection formulation for reducing body weight. The subcutaneous injection formulation for reducing body weight comprises drug-containing micelles made of a polyoxyethylene castor oil derivative or polyoxyethylene castor oil derivatives, and a curcuminoid or curcuminoids encapsulated in the drug-containing micelles. The subcutaneous injection formulation for reducing body weight can reduce body weight and visceral fat on overweight or obese subjects, and has the advantages of low dosage, high stability, high fat tissue bioavailability, few side effects, and sustained release.

Skin Care Compositions and Methods of Use Thereof

The present disclosure provides a mixture of sugar apple and rosemary extracts, optionally in combination with prickly ash extract, for use as skin care compositions.

Skin Care Compositions and Methods of Use Thereof

The present disclosure provides a mixture of sugar apple and rosemary extracts, optionally in combination with prickly ash extract, for use as skin care compositions.

VEGFC PRODUCTION PROMOTER

The purpose of this invention is to find a novel fragrance component effective for prevention or control of swelling, lymphedema, skin aging or obesity from the viewpoint of activation of lymph vessel function by promotion of the expression of VEGFC. This invention provides a swelling improving agent, lymph vessel activator and VEGFC production promoter characterized by containing one or a plurality of components selected from the group consisting of rose oxide, citronellyl acetate and niaouli oil.

VEGFC PRODUCTION PROMOTER

The purpose of this invention is to find a novel fragrance component effective for prevention or control of swelling, lymphedema, skin aging or obesity from the viewpoint of activation of lymph vessel function by promotion of the expression of VEGFC. This invention provides a swelling improving agent, lymph vessel activator and VEGFC production promoter characterized by containing one or a plurality of components selected from the group consisting of rose oxide, citronellyl acetate and niaouli oil.

GELLED COMPOSITION COMPRISING A DISPERSION OF SOLID AGGREGATES
20200222288 · 2020-07-16 ·

A composition, especially a cosmetic composition, in particular for making up and/or caring for keratin materials, including at least one aqueous phase gelled with at least one hydrophilic gelling agent; and at least one oily phase gelled with at least one lipophilic gelling agent chosen from organopolysiloxane elastomers; said phases forming therein a macroscopically homogeneous mixture. The composition also includes a dispersion of solid aggregates, said aggregates being formed from 10% to 80% by weight of wax(es), relative to their total weight. Also disclosed is a process for preparing such a composition.

THE TRANSDERMAL USE OF CYANOBACTERIAL ALGAE, AND/OR EXTRACTS THEREOF, VIA LOW OR HIGH INTENSITY TRANSPORATION DEVICES FOR BEAUTY AND HEALTH ENHANCING PURPOSES
20200222475 · 2020-07-16 ·

The present invention refers to the transporation, or force-transdermal vehiculation, of cyanobacterial algae or extracts thereof, through electroporation, sonoporation (sound), photoporation (light), radioporation (radio frequency), and through any other transporation tool for enhancing the transdermal penetration of cyanobacterial molecules via the transmission of some force, be it electric, or generated by sound, light and/or radio frequencies. The invention cover the use of whole cyanobacterial algae or extracts thereof, with different levels of transdermal penetration, be it the low intensity transporation, which can be used for deep aesthetic and skin regenerating purposes, as well as dermatological problems; or the high intensity transporation, able to penetrate deep though the dermis, and beyond the hypodermis into organs and tissues, and that can be uses for muscular, osteo-articular and metabolic problems. Following an exhaustive explanation of the invention, we present very significant results in different beauty and health areas.

Female menopause alleviation use of composition containing composite extract of red clover and pomegranate as active ingredient
10709750 · 2020-07-14 · ·

The present invention relates to: a natural composition containing a composite extract of pomegranates and red clover, exhibiting synergistic effects with respect to a menopausal symptom alleviation effect, an estrogen-like effect, an anti-obesity effect, a hyperlipidemia inhibitory effect, a fatty liver protective effect, an osteoporosis inhibitory effect and the like without any side effects; and various uses thereof, in particular, pharmaceutical, bromatological and cosmetic uses.

SKIN CARE COMPOSITIONS AND METHODS
20200214955 · 2020-07-09 ·

Skin care compositions, methods, and kits are provided. In some embodiments, the skin care compositions include one or more oils that include ximenynic acid, and one or more oils that include linolenic acid, and/or one or more oils that include linoleic acid. In certain embodiments, methods of using the aforementioned skin care formulations are provided for the treatment of acne, psoriasis, eczema, or dermatitis.

SKIN CARE COMPOSITIONS AND METHODS
20200214955 · 2020-07-09 ·

Skin care compositions, methods, and kits are provided. In some embodiments, the skin care compositions include one or more oils that include ximenynic acid, and one or more oils that include linolenic acid, and/or one or more oils that include linoleic acid. In certain embodiments, methods of using the aforementioned skin care formulations are provided for the treatment of acne, psoriasis, eczema, or dermatitis.